Your browser is no longer supported. Please, upgrade your browser.
ENZ Enzo Biochem, Inc. monthly Stock Chart
Enzo Biochem, Inc.
Index- P/E- EPS (ttm)-0.60 Insider Own7.65% Shs Outstand47.78M Perf Week1.03%
Market Cap95.35M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float44.23M Perf Month2.07%
Income-28.50M PEG- EPS next Q- Inst Own61.10% Short Float5.67% Perf Quarter-13.60%
Sales76.00M P/S1.25 EPS this Y- Inst Trans1.29% Short Ratio8.27 Perf Half Y-30.88%
Book/sh1.22 P/B1.61 EPS next Y- ROA-24.20% Target Price- Perf Year-28.10%
Cash/sh0.99 P/C1.99 EPS next 5Y- ROE-42.30% 52W Range1.56 - 4.85 Perf YTD-25.10%
Dividend- P/FCF- EPS past 5Y-64.00% ROI-43.20% 52W High-59.38% Beta0.77
Dividend %- Quick Ratio1.90 Sales past 5Y-4.90% Gross Margin31.30% 52W Low26.28% ATR0.10
Employees408 Current Ratio2.10 Sales Q/Q-6.70% Oper. Margin-40.00% RSI (14)48.35 Volatility2.97% 5.24%
OptionableYes Debt/Eq0.20 EPS Q/Q38.50% Profit Margin-37.50% Rel Volume0.44 Prev Close1.96
ShortableYes LT Debt/Eq0.08 EarningsOct 13 AMC Payout- Avg Volume303.12K Price1.97
Recom- SMA200.00% SMA50-6.07% SMA200-17.20% Volume134,471 Change0.51%
Oct-18-11Reiterated Rodman & Renshaw Mkt Outperform $7 → $5
Sep-23-09Initiated Rodman & Renshaw Mkt Outperform $14
Sep-13-07Initiated Lazard Capital Buy $19
Nov-25-20 08:00AM  
Nov-18-20 01:00PM  
Nov-17-20 08:00AM  
Nov-05-20 08:00AM  
Oct-27-20 08:00AM  
Oct-14-20 07:53AM  
Oct-13-20 04:01PM  
Oct-06-20 03:42PM  
Sep-15-20 09:29AM  
Sep-08-20 08:00AM  
Aug-03-20 03:15PM  
Jul-21-20 08:30AM  
Jul-17-20 01:56PM  
Jul-13-20 08:50AM  
Jun-30-20 01:15PM  
Jun-25-20 05:50PM  
Jun-23-20 08:30AM  
Jun-08-20 04:05PM  
Jun-03-20 04:05PM  
May-20-20 08:00AM  
May-12-20 08:00AM  
Apr-29-20 08:00AM  
Apr-23-20 08:00AM  
Mar-24-20 07:50AM  
Mar-20-20 06:00AM  
Mar-13-20 07:38PM  
Mar-09-20 02:44PM  
Mar-06-20 08:00AM  
Mar-05-20 04:05PM  
Mar-03-20 10:00AM  
Feb-25-20 10:27AM  
Feb-19-20 05:16PM  
Feb-12-20 09:18AM  
Feb-11-20 08:30AM  
Feb-07-20 08:00AM  
Feb-06-20 03:07PM  
Jan-30-20 08:13AM  
Jan-29-20 10:51AM  
Jan-28-20 05:45PM  
Jan-27-20 06:45AM  
Jan-21-20 02:36PM  
Jan-17-20 03:02PM  
Jan-16-20 01:03PM  
Jan-13-20 08:00AM  
Jan-08-20 09:00AM  
Dec-31-19 10:48AM  
Dec-30-19 09:00AM  
Dec-14-19 07:01PM  
Dec-10-19 04:15PM  
Dec-05-19 04:15PM  
Nov-09-19 09:18AM  
Oct-17-19 08:44PM  
Oct-15-19 04:15PM  
Oct-11-19 09:00AM  
Oct-10-19 08:06AM  
Sep-24-19 09:00AM  
Sep-17-19 09:00AM  
Sep-10-19 07:33AM  
Aug-15-19 07:43AM  
Aug-05-19 09:00AM  
Jul-17-19 10:48AM  
Jul-11-19 09:00AM  
Jul-02-19 07:12PM  
Jun-11-19 02:54PM  
Jun-10-19 04:17PM  
Jun-05-19 09:00AM  
May-10-19 10:48AM  
May-02-19 06:00AM  
Apr-23-19 02:19PM  
Apr-01-19 06:25PM  
Mar-11-19 04:50PM  
Mar-05-19 04:05PM  
Feb-26-19 12:45PM  
Jan-29-19 07:35AM  
Jan-06-19 11:36PM  
Jan-02-19 01:40PM  
Dec-10-18 04:21PM  
Dec-06-18 09:00AM  
Dec-03-18 09:00AM  
Nov-14-18 12:57PM  
Oct-29-18 08:25AM  
Oct-17-18 08:15AM  
Oct-16-18 09:42PM  
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Products, Clinical Services, and Therapeutics. The Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Services segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, or search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 34 patient service centers in New York and New Jersey; and a free-standing A'STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company markets its products and services through its direct sales force and a network of distributors in the United States and internationally. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CLEMENS PETER J IV10% OwnerFeb 18Buy2.204,0008,80015,000Feb 19 02:45 PM
CLEMENS PETER J IV10% OwnerFeb 14Buy2.216,00013,26011,000Feb 19 02:45 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.